-
Mashup Score: 1
Though the reasons aren’t clear, drops in estrogen likely play a significant role in accelerating plaque, says Matthew Budoff.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 15
New indications supported by CLEAR Outcomes trial
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 76Effect of Statin Use on Liver Enzymes and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) - 2 month(s) ago
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with the prevalence of approximately 30%.1 The prevalence goes up among specific high-risk populations: 30-50% in patients with type 2 diabetes, and 80-90% in patients with obesity.2,3
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Wegovy Approved for Major Heart Disease Prevention - 2 month(s) ago
New indication for patients with obesity or overweight and a history of cardiovascular disease
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Wegovy Approved for Major Heart Disease Prevention - 2 month(s) ago
New indication for patients with obesity or overweight and a history of cardiovascular disease
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 28Reinstating LDL-C Measurement as a Quality Metric: This Is the Way - 2 month(s) ago
Author links open overlay panel Christie M. Ballantyne MD a, Anandita Agarwala MD
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 26Reinstating LDL-C Measurement as a Quality Metric: This Is the Way - 2 month(s) ago
Author links open overlay panel Christie M. Ballantyne MD a, Anandita Agarwala MD
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Why Are We Lying to Our Doctors? - 2 month(s) ago
Alcohol use, exercise habits, nutrition—many patients are misrepresenting their health histories to their doctors. Linda Wells asks: Why?
Source: airmail.newsCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 96Choose Your Affiliation - NYU Health Sciences Library - 2 month(s) ago
Users with access to atnyulmc.org should login with their NYU Langone Credentials. Users with access to home.nyu.edu should login with their NYU Credentials. Still have questions? See our
Source: library.med.nyu.eduCategories: General Medicine News, CardiologistsTweet-
#LowerIsBetter 📉⬇️ Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting https://t.co/QL24pC607H Author Lay Summary 👉 “In this multicentre cohort comprising 33 968 patients at… https://t.co/mg7hOnQxf6 https://t.co/naY7bEtXlw
-
-
Mashup Score: 1CSL Announces Top-line Results from the Phase 3 AEGIS-II Trial Evaluating the Efficacy and Safety of CSL112 (apolipoprotein A-I [human]) - 3 month(s) ago
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced top-line results from the Phase 3 AEGIS-II trial evaluating the efficacy and safety of CSL112 (apolipoprotein A-I [human])…
Source: newsroom.csl.comCategories: General Medicine News, CardiologistsTweet
Faster CAC Progression After Menopause May Warrant Intensified Therapy https://t.co/bE96Xcczre